Rachit Khandelwal, Pediatrics BMT fellow at Medanta The Medicity, Gurgaon, shared a post on X:
“New insights on treating infant ALL:
– Advanced diagnostics
(KMT2A status, RNA-based fusion detection)
– Integration of immunotherapy (blinatumomab, CAR-T, SCT)
Promising outcomes with reduced toxicity.”
